Información de la revista
Ahead of print
"Ahead of print" son artículos aceptados y revisados pero que aún no han sido asignados a un volumen/número. Pueden ser citados usando el DOI - Saber más
Prognostic significance of normalized distance from maximum standardized uptake value to tumor centroid on [18F]FDG PET/CT in head and neck squamous cell carcinoma
Sun-pyo Hong, Sang Mi Lee, Ik Dong Yoo, In Young Jo, Yong Kyun Won, Min-Su Kim, Hye Jeong Choi, Jeong Won Lee, Su Jin Jang
10.1016/j.remnie.2025.500103
Disponible online el 13 de febrero de 2025
Correlation between metabolic response determined with [18F]FDG PET/CT and pathological response after neoadjuvant treatment and surgery in patients with esophageal cancer
J.R. Infante, J. Quirós, R. Barco, C. Bejarano, E. Agudo, J. Fernández, A. Baena, A. Utrera, ... J. Serrano
10.1016/j.remnie.2025.500088
Disponible online el 7 de febrero de 2025
The synergic effect of Multiparametric MRI and [18F]PSMA-1007 PET/CT imaging in recurrence work-up of locally advanced prostate adenocarcinoma
D. Schmitt, L. Schimmöller, E. Novruzov, J. Kirchner, M. Boschheidgen, E. Mamlins, C. Antke, Y. Mori, ... F.L. Giesel
10.1016/j.remnie.2025.500104
Disponible online el 7 de febrero de 2025
Rare imaging features of adult chronic recurrent multifocal osteomyelitis on PET/CT
R. Luo, W. Zhang, A. Kuang, Y. Li
10.1016/j.remnie.2025.500121
Disponible online el 3 de febrero de 2025
[18F]FDG PET/CT beyond staging: Prognostic significance of sarcopenia and adipose tissue metabolism in esophageal carcinomas
Merve Nur Acar Tayyar, Müge Öner Tamam, Gündüzalp Buğrahan Babacan, Mehmet Can Şahin, Halim Özçevik, Necla Gürdal, Kadir Atakır
10.1016/j.remnie.2024.500090
Disponible online el 31 de enero de 2025
Atypical muscle metastatic dissemination detected by [18F]FDG PET/CT in high-grade retroperitoneal leiomyosarcoma
R. Valverde-Jorge, M. Díez-García, I. Vinagre-Pérez, L. Mosteiro-González, I. Ratón-Zulueta, I. Fernández-Tercero
10.1016/j.remnie.2025.500094
Disponible online el 27 de enero de 2025
The relationship between HER2 status acquired from pathological data and metabolic parameters from pre-treatment [18F]FDG PET/CT in gastric adenocarcinomas
M.N. Acar Tayyar, M.Ö. Tamam, G.B. Babacan, M.C. Şahin, H. Özçevik, S. Şengiz Erhan, A.E. Öztürk
10.1016/j.remnie.2024.500080
Disponible online el 10 de enero de 2025
Comparison of the diagnostic performances of CT attenuation corrected and non-attenuation corrected SPECT myocardial perfusion scintigraphy in coronary artery disease
G. Kara Gedik, A. Volkan Çelik, M.U. Yalçın, M. Koplay, F. Yılmaz, H. Önner
10.1016/j.remnie.2024.500085
Disponible online el 9 de enero de 2025
Analysis of dosimetry and clinical variables in treatments of neuroendocrine tumours with [177Lu]Lu-DOTA-TATE
P. Mínguez Gabiña, T. Monserrat Fuertes, B. Santos Zorrozua, A. Esteban Figueruelo, M.A. Astudillo Sarmiento, A. Peña Fuentes, I. Vinagre Pérez, E. Rodeño Ortiz de Zarate, I.L. Fernández Tercero
10.1016/j.remnie.2024.500089
Disponible online el 7 de enero de 2025
Correlation between [18F]-FDG PET/CT findings and pathological subtypes of lung adenocarcinoma presenting as ground-glass opacity
H. Ji, S. Jiang, C. Sun, T. Liu, G. Yang, L. Zhang, J. Sun, J. Wu
10.1016/j.remnie.2024.500087
Disponible online el 7 de enero de 2025